Product NDC: | 0615-5530 |
Proprietary Name: | Lisinopril |
Non Proprietary Name: | Lisinopril |
Active Ingredient(s): | 5 mg/1 & nbsp; Lisinopril |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0615-5530 |
Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075752 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100420 |
Package NDC: | 0615-5530-31 |
Package Description: | 31 TABLET in 1 BLISTER PACK (0615-5530-31) |
NDC Code | 0615-5530-31 |
Proprietary Name | Lisinopril |
Package Description | 31 TABLET in 1 BLISTER PACK (0615-5530-31) |
Product NDC | 0615-5530 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lisinopril |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100420 |
Marketing Category Name | ANDA |
Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
Substance Name | LISINOPRIL |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |